Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATrX-1: Trabodenoson in Ocular Hypertension or Primary Open-angle Glaucoma
NCT02565173Phase 3Completed
- Sponsor
- Inotek Pharmaceuticals
- Start
- Sep 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trabodenoson in ocular hypertension, primary open-angle glaucoma (POAG), sponsored by Inotek Pharmaceuticals. Started Sep 2015; status: completed.
02
Drugs
trabodenoson
03
Conditions
ocular hypertensionprimary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT02565173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565173.